We are live on
!
Find out more
EC
EntryPoint Capital Portfolio holdings
AUM
$341M
1-Year Est. Return
20.57%
This Fund
S&P 500
This Quarter
Est. Return
-8.17%
1 Year Est. Return
+20.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$218M
AUM Growth
-$19.5M
(-8.2%)
Cap. Flow
+$3.51M
Cap. Flow
% of AUM
1.61%
Top 10 Holdings %
Top 10 Hldgs %
4.42%
Holding
1,001
New
307
Increased
177
Reduced
167
Closed
349
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AtriCure
ATRC
|
+$934K |
| 2 |
MASI
Masimo
MASI
|
+$931K |
| 3 |
Palladyne AI
PDYN
|
+$929K |
| 4 |
Equity Lifestyle Properties
ELS
|
+$926K |
| 5 |
BorgWarner
BWA
|
+$898K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Carlyle Group
CG
|
+$962K |
| 2 |
GeneDx Holdings
WGS
|
+$933K |
| 3 |
Viasat
VSAT
|
+$852K |
| 4 |
INFA
Informatica
INFA
|
+$807K |
| 5 |
Amgen
AMGN
|
+$804K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.61% |
| 2 | Technology | 17.16% |
| 3 | Industrials | 15.49% |
| 4 | Financials | 11.59% |
| 5 | Consumer Discretionary | 10.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PSIX
526
Power Solutions International
PSIX
$691M
| $205K | 0.09% |
+8,119
| New | +$280K |
|
527
AAR Corp
AIR
$5.15B
| $205K | 0.09% |
+3,661
| New | +$243K |
|
528
Assured Guaranty
AGO
$3.78B
| $205K | 0.09% |
+2,324
| New | +$208K |
|
529
Mercer International
MERC
$44.9M
| $205K | 0.09% |
33,288
+2,228
| +7% | +$15K |
|
530
Flotek Industries
FTK
$935M
| $204K | 0.09% |
+24,498
| New | +$212K |
|
531
Global Ship Lease
GSL
$1.57B
| $204K | 0.09% |
+8,925
| New | +$200K |
|
532
Johnson Outdoors
JOUT
$482M
| $203K | 0.09% |
+8,166
| New | +$238K |
|
533
Terreno Realty
TRNO
$7.68B
| $203K | 0.09% |
3,205
-2,847
| -47% | -$185K |
|
|
TERN
534
DELISTED
Terns Pharmaceuticals
TERN
| $202K | 0.09% |
73,293
+12,905
| +21% | +$52.7K |
|
535
Quanterix
QTRX
$173M
| $202K | 0.09% |
31,041
-4,463
| -13% | -$37.2K |
|
536
Principal Financial Group
PFG
$23.6B
| $202K | 0.09% |
+2,395
| New | +$199K |
|
537
Ouster
OUST
$2.29B
| $201K | 0.09% |
22,437
-26,241
| -54% | -$259K |
|
538
EPAM Systems
EPAM
$4.69B
| $201K | 0.09% |
1,193
-43
| -3% | -$9.48K |
|
539
Euronet Worldwide
EEFT
$3.02B
| $201K | 0.09% |
1,883
-1,340
| -42% | -$136K |
|
540
Antero Midstream
AM
$10.8B
| $201K | 0.09% |
11,175
-242
| -2% | -$4.01K |
|
541
CareDx
CDNA
$1.92B
| $201K | 0.09% |
11,308
-5,214
| -32% | -$112K |
|
|
PKST
542
DELISTED
Peakstone Realty Trust
PKST
| $200K | 0.09% |
+15,883
| New | +$180K |
|
543
Korea Electric Power
KEP
$15.5B
| $200K | 0.09% |
27,007
+8,622
| +47% | +$63.6K |
|
544
Metallus
MTUS
$873M
| $199K | 0.09% |
+14,893
| New | +$217K |
|
545
NOV
NOV
$7.45B
| $197K | 0.09% |
12,963
-16,273
| -56% | -$243K |
|
546
American Express Global Business Travel
GBTG
$4.91B
| $196K | 0.09% |
27,028
-23,814
| -47% | -$201K |
|
547
Xponential Fitness
XPOF
$265M
| $192K | 0.09% |
23,067
+9,890
| +75% | +$138K |
|
548
Janus International
JBI
$722M
| $190K | 0.09% |
26,341
-12,024
| -31% | -$95.5K |
|
549
STAAR Surgical
STAA
$1.16B
| $189K | 0.09% |
+10,735
| New | +$215K |
|
550
Taysha Gene Therapies
TSHA
$1.59B
| $189K | 0.09% |
135,897
+74,402
| +121% | +$124K |
|
Similar funds
SFA
FCM
CPI
SW
MTIC
KFSC
YCM
SC
EntryPoint Capital's Q1 2025 Portfolio in Review
As of Q1 2025, EntryPoint Capital held 1,001 positions worth $218M, down 8.2% from $238M the previous quarter. Its ten largest holdings account for 4.4% of the portfolio.
EntryPoint Capital's Q1 2025 filing shows 307 new, 177 increased, 167 reduced and 349 closed positions. Its largest new stake was AtriCure: 25,168 shares worth $812K. The largest sale was Carlyle Group, an estimated $962K.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.
- EntryPoint Capital's largest Q1 2025 buy was AtriCure: 25,168 shares worth $812K.
- EntryPoint Capital added most to Amphenol in Q1 2025, an estimated $815K increase.
- EntryPoint Capital's biggest Q1 2025 reduction was Harmony Biosciences, cutting an estimated $692K.
- EntryPoint Capital fully exited Carlyle Group in Q1 2025, selling an estimated $962K.
- EntryPoint Capital's ten largest holdings make up 4.4% of its $218M portfolio in Q1 2025.
- EntryPoint Capital opened 307 new positions and closed 349 in Q1 2025.
- EntryPoint Capital's portfolio value fell 8.2% quarter-over-quarter to $218M.
Based on EntryPoint Capital's 13F filing for Q1 2025, filed 14 May 2025.